Projects per year
Personal profile
Education
- 2009 Ph.D., Graduate Institute of Clinical Medicine, Taipei Medical University
- 1985-1992 M.D., School of Medicine, National Taiwan University
Experience
- 2019.01- Vice Superintendent, Taipei Medical University Hospital
- 2017.08- Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2020.11-2021.07 Director, Department of Nuclear Medicine, Taipei Medical University Hospital
- 2016.06-2017.07 Deputy Director, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2015 Vice Chairman, Department of Surgery, Taipei Medical University Hospital
- 2015 Chairman, Department of Quality Management, Taipei Medical University Hospital
- 2014.08- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.02- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical university
- 2012.08-2015.07 Associate Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2009.08-2012.07 Assistant Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2008 Chief, Division of General Surgery, Taipei Medical University Hospital
- 2006 Attending Doctor, General Surgery, Taipei Medical University Hospital
- 2006.02-2009.07 Instructor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2005.12-2006.05 Director, Division of Rectal Surgery, Min-Sheng Hospital
- 2004.07-2005.11 Director, Division of General Surgery, En Chu Kong Hospital
- 2003.07-2004.06 Director, Division of Rectal Surgery, En Chu Kong Hospital
- 1997.07-2006.06 Attending Physician, Department of Surgery, En Chu Kong Hospital
- 1992.07-1997.06 Resident Physician, Department of Surgery, National Taiwan University Hospital
Awards
- 2015 Faculty Award of Taipei Medical University
- 2015 Distinguished Teaching Award of College of Medicine, Taipei Medical University
- 2013 Best Advisor Award of College of Medicine, Taipei Medical University
- 2011 The excellent thesis of the year 2010 by international college of surgeons
Research Interests
- Cancer molecular biology
- Signal transduction
- ER stress and metastasis
- Colorectal Surgery
Related Link
Fingerprint
Dive into the research topics where Po-Li Wei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
研究MSN在大腸直腸癌中對病程進展的調控機制和其治療角色
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討PCTK1激?蛋白在大腸直腸癌發展的角色及其調控機制(延續計畫)(3/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism (Continuation Project)(2/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism (Continuation Project)(1/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
Wang, W. L., Batzorig, U., Hung, C. S., Wei, P. L., Huang, C. Y. & Chang, Y. J., 2022, In: BioMed Research International. 2022, 1322788.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Cigarette Smoking Associated with Colorectal Cancer Survival: A Nationwide, Population-Based Cohort Study
Huang, Y. M., Wei, P. L., Ho, C. H. & Yeh, C. C., Feb 2 2022, In: Journal of Clinical Medicine. 11, 4, 913.Research output: Contribution to journal › Article › peer-review
Open Access -
Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway
Wei, P. L., Lin, J. C., Hung, C. S., Makondi, P. T., Batzorig, U., Chang, T. C., Huang, C. Y. & Chang, Y. J., 2022, In: International Journal of Medical Sciences. 19, 1, p. 34-46 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Microtube Array Membrane Hollow Fiber Assay (MTAM-HFA)—An Accurate and Rapid Potential Companion Diagnostic and Pharmacological Interrogation Solution for Cancer Immunotherapy (PD-1/PD-L1)
Huang, W. T., Yun, T., Chew, C. H., Chen, A., Wei, P. L., Lee, K. Y., Lee, H. L., Feng, P. H., Chiou, J. F., Chen, C. M. & Chen, C. C., Apr 2022, In: Biomolecules. 12, 4, 480.Research output: Contribution to journal › Article › peer-review
Open Access -
Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling
Leung, W. H., Shih, J. W., Chen, J. S., Mokgautsi, N., Wei, P. L. & Huang, Y. J., Feb 2022, In: Biomedicines. 10, 2, 377.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Yeh, Y. (Contributor), Tsai, H. (Contributor), Huang, C. (Contributor), Wei, P. (Contributor), Sung, Y. (Contributor), Tang, H. (Contributor) & Wang, J. (Contributor), Unknown Publisher, Apr 26 2017
DOI: 10.6084/m9.figshare.c.3751544.v1, https://figshare.com/collections/Maintenance_tegafur-uracil_versus_observation_following_an_adjuvant_oxaliplatin-based_regimen_in_patients_with_stage_III_colon_cancer_after_radical_resection_study_protocol_for_a_randomized_controlled_trial/3751544/1
Dataset
-
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Contributor), Meng, T. (Contributor), Hsiao, M. (Contributor), Tzeng, Y. (Contributor), Wu, A. T. (Contributor) & Yen, Y. (Contributor), Unknown Publisher, Feb 28 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://springernature.figshare.com/articles/presentation/Additional_file_2_Figure_S1_of_Ovatodiolide_suppresses_colon_tumorigenesis_and_prevents_polarization_of_M2_tumor-associated_macrophages_through_YAP_oncogenic_pathways/4701505/1
Dataset
-
Additional file 1: Figure S2. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Contributor), Meng, T. (Contributor), Hsiao, M. (Contributor), Tzeng, Y. (Contributor), Wu, A. T. (Contributor) & Yen, Y. (Contributor), Unknown Publisher, Feb 28 2017
DOI: 10.6084/m9.figshare.c.3704533_d2.v1, https://springernature.figshare.com/articles/presentation/Additional_file_1_Figure_S2_of_Ovatodiolide_suppresses_colon_tumorigenesis_and_prevents_polarization_of_M2_tumor-associated_macrophages_through_YAP_oncogenic_pathways/4701517/1
Dataset
-
Additional file 1: of Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Yeh, Y. (Contributor), Tsai, H. (Contributor), Huang, C. (Contributor), Wei, P. (Contributor), Sung, Y. (Contributor), Tang, H. (Contributor) & Wang, J. (Contributor), Unknown Publisher, Apr 26 2017
DOI: 10.6084/m9.figshare.c.3751544_d1.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Maintenance_tegafur-uracil_versus_observation_following_an_adjuvant_oxaliplatin-based_regimen_in_patients_with_stage_III_colon_cancer_after_radical_resection_study_protocol_for_a_randomized_controlled_trial/4909706/1
Dataset
-
Additional file 3 of EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody
Huang, H. (Contributor), Wei, P. (Contributor), Sung, T. (Contributor), Chang, F. (Contributor), Cheng, Y. (Contributor), HuangFu, W. (Contributor), Lee, Y. (Contributor), Cheng, C. (Contributor), Huang, C. (Contributor) & Pan, S. (Contributor), figshare Academic Research System, 2021
DOI: 10.6084/m9.figshare.14228284.v1, https://doi.org/10.6084%2Fm9.figshare.14228284.v1
Dataset